Publication
Title
Recent advances in Charcot-Marie-Tooth disease
Author
Abstract
Purpose of review: This article focuses on recent advances in CharcotMarieTooth disease, in particular additions to the genetic spectrum, novel paradigms in molecular techniques and an update on therapeutic strategies. Recent findings: Several new CharcotMarieTooth disease-causing genes have been recently identified, further enlarging the genetic diversity and phenotypic variability, including: SBF1, DHTKD1, TFG, MARS, HARS, HINT1, TRIM1, AIFM1, PDK3 and GNB4. The increasing availability and affordability of next-generation sequencing technologies has ramped up gene discovery and drastically changed genetic screening strategies. All large-scale trials studying the effect of ascorbic acid in CharcotMarieTooth 1A have now been completed and were negative. Efforts have been made to design more robust outcome-measures for clinical trials. Promising results with lonaprisan, curcumin and histone deacetylase 6 inhibitors have been obtained in animal models. Summary: CharcotMarieTooth is the most common form of inherited peripheral neuropathy and represents the most prevalent hereditary neuromuscular disorder. The genetic spectrum spans more than 70 genes. Gene discovery has been revolutionized recently by new high-throughput molecular technologies. In addition, the phenotypic diversity has grown tremendously. This is a major challenge for geneticists and neurologists. No effective therapy is available for CharcotMarieTooth. Several large trials with ascorbic acid were negative but research into novel compounds continues.
Language
English
Source (journal)
Current opinion in neurology. - Philadelphia, Pa., 1993, currens
Publication
Philadelphia, Pa. : 2014
ISSN
1350-7540 [print]
1473-6551 [online]
DOI
10.1097/WCO.0000000000000131
Volume/pages
27 :5 (2014) , p. 532-540
ISI
000341856200005
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Project info
VIB-Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS).
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 31.10.2014
Last edited 09.10.2023
To cite this reference